Patents by Inventor Heimo WINKLER

Heimo WINKLER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Abuse-deterrent pharmaceutical composition
    Patent number: 11077196
    Abstract: Disclosed is an abuse-deterrent pharmaceutical composition comprising a drug with an enzyme-reactive functional group, wherein the drug has an abuse potential, and an enzyme capable of reacting with the enzyme-reactive functional group (a drug-processing enzyme), wherein the drug with the enzyme-reactive functional group is contained in the pharmaceutical composition in a storage stable, enzyme-reactive state and under conditions wherein no enzymatic activity acts on the drug.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: August 3, 2021
    Assignee: G.L. PHARMA GMBH
    Inventors: Georg Guebitz, Katrin Greimel, Martin Brandauer, Daniela Huber, Klaus Bleymaier, Wolfgang Kroutil, Doris Lechner, Christof Wachter, Harald Wagner, Heimo Winkler
  • Abuse-deterrent pharmaceutical compositions
    Publication number: 20200261585
    Abstract: Disclosed are pharmaceutical compositions comprising oxycodone and an oxycodone-processing enzyme, wherein oxycodone is contained in the pharmaceutical composition in a storage stable, enzyme-reactive state and under conditions wherein no enzymatic activity acts on oxycodone.
    Type: Application
    Filed: April 9, 2020
    Publication date: August 20, 2020
    Applicant: G.L. PHARMA GMBH
    Inventors: Georg GUEBITZ, Katrin Greimel, Martin Brandauer, Daniela Huber, Klaus Bleymaier, Wolfgang Kroutil, Doris Lechner, Christof Wachter, Harald Wagner, Heimo Winkler
  • Abuse-deterrent pharmaceutical compositions
    Patent number: 10702607
    Abstract: Disclosed are pharmaceutical compositions comprising oxycodone and an oxycodone-processing enzyme, wherein oxycodone is contained in the pharmaceutical composition in a storage stable, enzyme-reactive state and under conditions wherein no enzymatic activity acts on oxycodone.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: July 7, 2020
    Assignee: G.L. PHARMA GMBH
    Inventors: Georg Guebitz, Katrin Greimel, Martin Brandauer, Daniela Huber, Klaus Bleymaier, Wolfgang Kroutil, Doris Lechner, Christof Wachter, Harald Wagner, Heimo Winkler
  • ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS
    Publication number: 20190070268
    Abstract: Disclosed are pharmaceutical compositions comprising a drug with a laccase-reactive functional group and a laccase (EC.10.3.2) and methods for manufacturing such compositions.
    Type: Application
    Filed: February 28, 2017
    Publication date: March 7, 2019
    Applicant: G. L. PHARMA GMBH
    Inventors: Georg GUEBITZ, Katrin GREIMEL, Martin BRANDAUER, Daniela HUBER, Klaus BLEYMAIER, Wolfgang KROUTIL, Doris LECHNER, Christof WACHTER, Harald WAGNER, Heimo WINKLER
  • ABUSE-DETERRENT PHARMACEUTICAL COMPOSITION
    Publication number: 20190060471
    Abstract: Disclosed is an abuse-deterrent pharmaceutical composition comprising a drug with an enzyme-reactive functional group, wherein the drug has an abuse potential, and an enzyme capable of reacting with the enzyme-reactive functional group (a drug-processing enzyme), wherein the drug with the enzyme-reactive functional group is contained in the pharmaceutical composition in a storage stable, enzyme-reactive state and under conditions wherein no enzymatic activity acts on the drug.
    Type: Application
    Filed: February 28, 2017
    Publication date: February 28, 2019
    Applicant: G.L. PHARMA GMBH
    Inventors: Georg GUEBITZ, Katrin GREIMEL, Martin BRANDAUER, Daniela HUBER, Klaus BLEYMAIER, Wolfgang KROUTIL, Doris LECHNER, Christof WACHTER, Harald WAGNER, Heimo WINKLER
  • ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS
    Publication number: 20190060470
    Abstract: Disclosed are pharmaceutical compositions comprising oxycodone and an oxycodone-processing enzyme, wherein oxycodone is contained in the pharmaceutical composition in a storage stable, enzyme-reactive state and under conditions wherein no enzymatic activity acts on oxycodone.
    Type: Application
    Filed: February 28, 2017
    Publication date: February 28, 2019
    Applicant: G.L. PHARMA GMBH
    Inventors: Georg GUBITZ, Katrin GREIMEL, Martin BRANDAUER, Daniela HUBER, Klaus BLEYMAIER, Wolfgang KROUTIL, Doris LECHNER, Christof WACHTER, Harald WAGNER, Heimo WINKLER